The Onset Time of Rocuronium in Emergency and Elective Surgery
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to
provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds
after intravenous injection, patients can be intubated.
Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients
undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of
this study is to investigate the effect of patient anxiety levels on the onset time of
rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.
Phase:
Phase 3
Details
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital